An experimental cure for Type 1 diabetes has a nearly 80 percent success rate. The results offer possible hope of curing a disease that affects 3 million Americans.
A new discovery about the wound-healing process could lead to better treatments for diabetics and other patients who have wounds that are slow to heal.
Self-reliant diabetes patients had a 33 percent higher mortality rate during a 5-year study, compared to diabetes patients who interacted easily with others and sought support.
With careful coaxing, stem cells from the brain can form insulin-producing cells that mimic those missing in people with diabetes.
Researchers have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes. The breakthrough may one day lead to new treatments or even a cure for the millions of people affected by the disease, researchers say.
Scientists have discovered what may be an important clue to the cause of type 1 diabetes. Nearly half of study participants had an abnormal immune response to wheat proteins.
Researchers have now carefully crafted a combination therapy that reverses recent-onset type 1 diabetes in 2 models of disease.
Researchers are capitalizing on the memories of stem cells generated from adult cells to bring new hope to sufferers of juvenile or type 1 diabetes.
The cause of insulin-dependent, permanent, diabetes in newborn babies may be a deficiency in the enzyme Pancreatic Endoplasmic Reticulum Kinase (PERK) during a critical period of development before birth.
Diabetes mellitus was linked to a 65 percent increased risk of developing Alzheimer's disease (AD), appearing to affect some aspects of cognitive function differently than others in a new study.
According to a new study, youth with type 1 diabetes have now been found to have abnormal insulin resistance.
New findings in clinical and basic science transplantation research to be presented; results of a study that treated diabetic children with a combination of cells from a pig’s pancreas and testes, and findings from three separate studies with a common goal in mind: to wean organ transplant patients off all anti-rejection drugs less than one year after transplantation, defying the tenet that such drugs are required for life.
Joslin Diabetes Center has launched a new affiliation program designed to bring Joslin's world-class vision resources to local communities across the United States and beyond.
Scientists have found clues to why patients with insulin-dependent diabetes are often unable to sense their need to take life-saving glucose.